Talis Biomedical Pink Sheet Forecast - Naive Prediction
| TLIS Stock | USD 2.84 0.00 0.00% |
The Naive Prediction forecasted value of Talis Biomedical Corp on the next trading day is expected to be 2.72 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 8.86. Talis Pink Sheet Forecast is based on your current time horizon.
At this time The relative strength index (RSI) of Talis Biomedical's share price is above 80 . This usually implies that the pink sheet is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 100
Buy Peaked
Oversold | Overbought |
Using Talis Biomedical hype-based prediction, you can estimate the value of Talis Biomedical Corp from the perspective of Talis Biomedical response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Talis Biomedical Corp on the next trading day is expected to be 2.72 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 8.86. Talis Biomedical after-hype prediction price | USD 2.84 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Talis |
Talis Biomedical Additional Predictive Modules
Most predictive techniques to examine Talis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Talis using various technical indicators. When you analyze Talis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Talis Biomedical Naive Prediction Price Forecast For the 23rd of January
Given 90 days horizon, the Naive Prediction forecasted value of Talis Biomedical Corp on the next trading day is expected to be 2.72 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.04, and the sum of the absolute errors of 8.86.Please note that although there have been many attempts to predict Talis Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Talis Biomedical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Talis Biomedical Pink Sheet Forecast Pattern
| Backtest Talis Biomedical | Talis Biomedical Price Prediction | Buy or Sell Advice |
Talis Biomedical Forecasted Value
In the context of forecasting Talis Biomedical's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Talis Biomedical's downside and upside margins for the forecasting period are 0.03 and 12.49, respectively. We have considered Talis Biomedical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Talis Biomedical pink sheet data series using in forecasting. Note that when a statistical model is used to represent Talis Biomedical pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.9411 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1453 |
| MAPE | Mean absolute percentage error | 0.0748 |
| SAE | Sum of the absolute errors | 8.8646 |
Predictive Modules for Talis Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Talis Biomedical Corp. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Talis Biomedical After-Hype Price Prediction Density Analysis
As far as predicting the price of Talis Biomedical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Talis Biomedical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Talis Biomedical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Talis Biomedical Estimiated After-Hype Price Volatility
In the context of predicting Talis Biomedical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Talis Biomedical's historical news coverage. Talis Biomedical's after-hype downside and upside margins for the prediction period are 0.14 and 12.61, respectively. We have considered Talis Biomedical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Talis Biomedical is dangerous at this time. Analysis and calculation of next after-hype price of Talis Biomedical Corp is based on 3 months time horizon.
Talis Biomedical Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Talis Biomedical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Talis Biomedical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Talis Biomedical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.20 | 9.77 | 0.00 | 0.03 | 0 Events / Month | 5 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.84 | 2.84 | 0.00 |
|
Talis Biomedical Hype Timeline
Talis Biomedical Corp is at this time traded for 2.84. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.03. Talis is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 1.2%. %. The volatility of related hype on Talis Biomedical is about 40708.33%, with the expected price after the next announcement by competition of 2.87. About 52.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.06. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Talis Biomedical Corp recorded a loss per share of 28.02. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 6th of July 2023. Given the investment horizon of 90 days the next forecasted press release will be within a week. Check out Historical Fundamental Analysis of Talis Biomedical to cross-verify your projections.Talis Biomedical Related Hype Analysis
Having access to credible news sources related to Talis Biomedical's direct competition is more important than ever and may enhance your ability to predict Talis Biomedical's future price movements. Getting to know how Talis Biomedical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Talis Biomedical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRT | Marti Technologies | (0.01) | 8 per month | 2.43 | (0.03) | 7.59 | (4.02) | 20.77 | |
| TIMB | TIM Participacoes SA | (0.03) | 9 per month | 1.90 | 0.03 | 3.06 | (2.72) | 8.26 | |
| CCCC | C4 Therapeutics | 0.36 | 8 per month | 0.00 | (0.03) | 8.16 | (7.32) | 24.93 | |
| HOLO | MicroCloud Hologram | (0.01) | 10 per month | 0.00 | (0.14) | 5.57 | (8.22) | 15.30 | |
| IMMR | Immersion | 0.13 | 12 per month | 2.19 | (0.03) | 4.57 | (3.90) | 22.47 | |
| ABSOF | ABS CBN Holdings | 0.00 | 0 per month | 0.00 | (0.14) | 0.00 | 0.00 | 40.00 | |
| HRZN | Horizon Technology Finance | (0.01) | 8 per month | 0.79 | 0.12 | 2.53 | (1.59) | 11.64 | |
| LLYVK | Liberty Live Holdings | (0.05) | 5 per month | 0.00 | (0.14) | 2.12 | (2.93) | 10.93 | |
| LSIIX | Loomis Sayles Investment | 0.00 | 0 per month | 0.16 | (0.59) | 0.20 | (0.30) | 0.61 | |
| HPQ | HP Inc | (0.14) | 10 per month | 0.00 | (0.27) | 2.73 | (3.97) | 10.78 |
Other Forecasting Options for Talis Biomedical
For every potential investor in Talis, whether a beginner or expert, Talis Biomedical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Talis Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Talis. Basic forecasting techniques help filter out the noise by identifying Talis Biomedical's price trends.Talis Biomedical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Talis Biomedical pink sheet to make a market-neutral strategy. Peer analysis of Talis Biomedical could also be used in its relative valuation, which is a method of valuing Talis Biomedical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Talis Biomedical Market Strength Events
Market strength indicators help investors to evaluate how Talis Biomedical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Talis Biomedical shares will generate the highest return on investment. By undertsting and applying Talis Biomedical pink sheet market strength indicators, traders can identify Talis Biomedical Corp entry and exit signals to maximize returns.
Talis Biomedical Risk Indicators
The analysis of Talis Biomedical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Talis Biomedical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting talis pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.96 | |||
| Standard Deviation | 10.03 | |||
| Variance | 100.6 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Talis Biomedical
The number of cover stories for Talis Biomedical depends on current market conditions and Talis Biomedical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Talis Biomedical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Talis Biomedical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Talis Biomedical Short Properties
Talis Biomedical's future price predictability will typically decrease when Talis Biomedical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Talis Biomedical Corp often depends not only on the future outlook of the potential Talis Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Talis Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.8 M | |
| Cash And Short Term Investments | 76.7 M |
Additional Tools for Talis Pink Sheet Analysis
When running Talis Biomedical's price analysis, check to measure Talis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talis Biomedical is operating at the current time. Most of Talis Biomedical's value examination focuses on studying past and present price action to predict the probability of Talis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talis Biomedical's price. Additionally, you may evaluate how the addition of Talis Biomedical to your portfolios can decrease your overall portfolio volatility.